1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghori, N; Haldar, K; Lauer, SA | 1 |
Abe, A; Lee, L; Shayman, JA; Shu, L | 1 |
Csaba, G; Kovács, P; Pintér, M | 1 |
Kono, Y; Kuroiwa, N; Nakamura, M; Takatsuki, A | 1 |
4 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
Article | Year |
---|---|
Sphingolipid synthesis as a target for chemotherapy against malaria parasites.
Topics: Animals; Antimalarials; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Golgi Apparatus; Humans; Kinetics; Malaria, Falciparum; Morpholines; Plasmodium falciparum; Sphingolipids; Transferases (Other Substituted Phosphate Groups) | 1995 |
Inhibitors of glucosylceramide synthase.
Topics: Cell Division; Ceramides; Drug Carriers; Enzyme Inhibitors; Glucosylceramides; Glucosyltransferases; Glycosphingolipids; Morpholines; Propanolamines; Pyrrolidines; Sphingolipids; Stereoisomerism | 2000 |
Effect of glucosphingolipid synthesis inhibitor (PPMP and PDMP) treatment on Tetrahymena pyriformis: data on the evolution of the signaling system.
Topics: Animals; Cytoskeleton; Glucosyltransferases; Glycosphingolipids; Morpholines; Signal Transduction; Sphingolipids; Tetrahymena pyriformis | 2000 |
Glucosylceramide synthesis inhibitors block pharmacologically induced dispersal of the Golgi and anterograde membrane flow from the endoplasmic reticulum: implication of sphingolipid metabolism in maintenance of the Golgi architecture and anterograde memb
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Brefeldin A; Cell Line; Cell Membrane; Endoplasmic Reticulum; Enzyme Inhibitors; Fluorescent Dyes; Glucosylceramides; Golgi Apparatus; Lipoxygenase Inhibitors; Masoprocol; Microscopy, Fluorescence; Microtubules; Morpholines; Nocodazole; Rats; Sphingolipids | 2001 |